Φορτώνει......
Treating cancer when pRb and p53 cannot be reactivated
Activation of oncoproteins and inactivation of tumor suppressors induces tumorigenesis. When these events happen upstream of pRb and p53, cancer therapies may initially succeed and then fail when pRb and p53 are activated and then re-inactivated. Therapies might succeed if they remain effective when...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Mol Cell Oncol |
|---|---|
| Κύριος συγγραφέας: | |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Taylor & Francis
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4905341/ https://ncbi.nlm.nih.gov/pubmed/27308498 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2015.1004954 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|